BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 33082451)

  • 1. Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses.
    Kosuge M; Furusawa-Nishii E; Ito K; Saito Y; Ogasawara K
    Sci Rep; 2020 Oct; 10(1):17766. PubMed ID: 33082451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.
    Simmonds P
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.
    Di Giorgio S; Martignano F; Torcia MG; Mattiuz G; Conticello SG
    Sci Adv; 2020 Jun; 6(25):eabb5813. PubMed ID: 32596474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations.
    Laamarti M; Alouane T; Kartti S; Chemao-Elfihri MW; Hakmi M; Essabbar A; Laamarti M; Hlali H; Bendani H; Boumajdi N; Benhrif O; Allam L; El Hafidi N; El Jaoudi R; Allali I; Marchoudi N; Fekkak J; Benrahma H; Nejjari C; Amzazi S; Belyamani L; Ibrahimi A
    PLoS One; 2020; 15(11):e0240345. PubMed ID: 33170902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host Immune Response Driving SARS-CoV-2 Evolution.
    Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Expansion of a Novel SARS-CoV-2 Mutant.
    Wang M; Li M; Ren R; Li L; Chen EQ; Li W; Ying B
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269121
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV and SARS-CoV-2: points to consider to face this new pandemic.
    Prieto Pozo AA; Salvador Sagüez FLD
    Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.
    Ratcliff J; Simmonds P
    Virology; 2021 Apr; 556():62-72. PubMed ID: 33545556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
    Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N
    PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.
    Sacchi A; Grassi G; Bordoni V; Lorenzini P; Cimini E; Casetti R; Tartaglia E; Marchioni L; Petrosillo N; Palmieri F; D'Offizi G; Notari S; Tempestilli M; Capobianchi MR; Nicastri E; Maeurer M; Zumla A; Locatelli F; Antinori A; Ippolito G; Agrati C
    Cell Death Dis; 2020 Oct; 11(10):921. PubMed ID: 33110074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Insights into Immune Responses during COVID-19.
    St John AL; Rathore APS
    J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
    Vishnubalaji R; Shaath H; Alajez NM
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.
    Lian J; Jin X; Hao S; Jia H; Cai H; Zhang X; Hu J; Zheng L; Wang X; Zhang S; Ye C; Jin C; Yu G; Gu J; Lu Y; Yu X; Xiang D; Li L; Liang T; Sheng J; Yang Y
    Influenza Other Respir Viruses; 2020 Sep; 14(5):564-574. PubMed ID: 32397011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
    Deng W; Bao L; Liu J; Xiao C; Liu J; Xue J; Lv Q; Qi F; Gao H; Yu P; Xu Y; Qu Y; Li F; Xiang Z; Yu H; Gong S; Liu M; Wang G; Wang S; Song Z; Liu Y; Zhao W; Han Y; Zhao L; Liu X; Wei Q; Qin C
    Science; 2020 Aug; 369(6505):818-823. PubMed ID: 32616673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.
    Klimczak LJ; Randall TA; Saini N; Li JL; Gordenin DA
    PLoS One; 2020; 15(10):e0237689. PubMed ID: 33006981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
    Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
    J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.